CD30, Th2 cytokines and HIV infection: a complex and fascinating link
- PMID: 7888070
- DOI: 10.1016/0167-5699(95)80092-1
CD30, Th2 cytokines and HIV infection: a complex and fascinating link
Abstract
CD30 is a member of the tumor necrosis factor (TNF)/nerve growth factor (NGF) receptor superfamily, and was originally described as a marker of Hodgkin's and Reed-Sternberg cells in Hodgkin's lymphoma. CD30 is preferentially expressed on CD4+ and CD8+ T-cell clones that produce T helper 2 (Th2)-type cytokines, and is also released in a soluble form by these cells. Elevated serum levels of soluble (s)CD30 have been found in some conditions in which a pathogenic role for Th2 cells has been suggested, such as atopy, Omenn's syndrome, systemic lupus erythematosus, as well as following infection with measles virus or human immuno-deficiency virus (HIV). Here, Gianfranco Del Prete and colleagues suggest a complex and fascinating link between the expression and release of CD30, and the immunopathogenesis of HIV infection.
Similar articles
-
CD30 and type 2 T helper (Th2) responses.J Leukoc Biol. 1995 May;57(5):726-30. doi: 10.1002/jlb.57.5.726. J Leukoc Biol. 1995. PMID: 7759952 Review.
-
Role for CD30 antigen in human T helper 2-type responses.Ciba Found Symp. 1995;195:55-62; discussion 62-7. doi: 10.1002/9780470514849.ch5. Ciba Found Symp. 1995. PMID: 8724830 Review.
-
CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection.J Exp Med. 1994 Dec 1;180(6):2407-11. doi: 10.1084/jem.180.6.2407. J Exp Med. 1994. PMID: 7964515 Free PMC article. Clinical Trial.
-
CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.Eur J Immunol. 1996 Feb;26(2):329-34. doi: 10.1002/eji.1830260209. Eur J Immunol. 1996. PMID: 8617299
-
Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?Br J Dermatol. 1998 May;138(5):774-9. doi: 10.1046/j.1365-2133.1998.02212.x. Br J Dermatol. 1998. PMID: 9666821
Cited by
-
CD26 Immuno-Expression and Periodontal Disease Progression.J Biomed Biotechnol. 2001;1(2):91-94. doi: 10.1155/S1110724301000195. J Biomed Biotechnol. 2001. PMID: 12488616 Free PMC article.
-
CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity.Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9699-703. doi: 10.1073/pnas.93.18.9699. Proc Natl Acad Sci U S A. 1996. PMID: 8790394 Free PMC article.
-
Hodgkin's lymphoma and CD30 signal transduction.Int J Hematol. 2003 Jan;77(1):37-47. doi: 10.1007/BF02982601. Int J Hematol. 2003. PMID: 12568298 Review.
-
Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response.Clin Exp Immunol. 1998 Oct;114(1):61-5. doi: 10.1046/j.1365-2249.1998.00672.x. Clin Exp Immunol. 1998. PMID: 9764604 Free PMC article.
-
Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.BMC Infect Dis. 2012 Apr 25;12:102. doi: 10.1186/1471-2334-12-102. BMC Infect Dis. 2012. PMID: 22533731 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
